252 related articles for article (PubMed ID: 29922050)
1. Factors associated with lung cancer in COPD patients.
Sandelin M; Mindus S; Thuresson M; Lisspers K; Ställberg B; Johansson G; Larsson K; Janson C
Int J Chron Obstruct Pulmon Dis; 2018; 13():1833-1839. PubMed ID: 29922050
[TBL] [Abstract][Full Text] [Related]
2. Inhaled corticosteroids in COPD and the risk of lung cancer.
Lee YM; Kim SJ; Lee JH; Ha E
Int J Cancer; 2018 Nov; 143(9):2311-2318. PubMed ID: 29943812
[TBL] [Abstract][Full Text] [Related]
3. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
Kiri VA; Fabbri LM; Davis KJ; Soriano JB
Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832
[TBL] [Abstract][Full Text] [Related]
4. Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD.
Wu MF; Jian ZH; Huang JY; Jan CF; Nfor ON; Jhang KM; Ku WY; Ho CC; Lung CC; Pan HH; Wu MC; Liaw YP
BMC Cancer; 2016 Oct; 16(1):778. PubMed ID: 27724847
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids have a protective effect against lung cancer in female patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study.
Liu SF; Kuo HC; Lin MC; Ho SC; Tu ML; Chen YM; Chen YC; Fang WF; Wang CC; Liu GH
Oncotarget; 2017 May; 8(18):29711-29721. PubMed ID: 28412726
[TBL] [Abstract][Full Text] [Related]
6. Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD - Real-World Data from a Primary Care Setting.
Ellingsen J; Johansson G; Larsson K; Lisspers K; Malinovschi A; Ställberg B; Thuresson M; Janson C
Int J Chron Obstruct Pulmon Dis; 2020; 15():235-245. PubMed ID: 32099348
[TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroids can reduce osteoporosis in female patients with COPD.
Liu SF; Kuo HC; Liu GH; Ho SC; Chang HC; Huang HT; Chen YM; Huang KT; Chen KY; Fang WF; Lin MC
Int J Chron Obstruct Pulmon Dis; 2016; 11():1607-14. PubMed ID: 27478374
[TBL] [Abstract][Full Text] [Related]
8. Associations among chronic obstructive pulmonary disease with asthma, pneumonia, and corticosteroid use in the general population.
Yeh JJ; Lin CL; Kao CH
PLoS One; 2020; 15(2):e0229484. PubMed ID: 32092112
[TBL] [Abstract][Full Text] [Related]
9. Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study.
Raymakers AJN; Sadatsafavi M; Sin DD; FitzGerald JM; Marra CA; Lynd LD
Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 30956205
[TBL] [Abstract][Full Text] [Related]
10. The use of corticosteroids in patients with COPD or asthma does not decrease lung squamous cell carcinoma.
Jian ZH; Huang JY; Lin FC; Nfor ON; Jhang KM; Ku WY; Ho CC; Lung CC; Pan HH; Liang YC; Wu MF; Liaw YP
BMC Pulm Med; 2015 Dec; 15():154. PubMed ID: 26634452
[TBL] [Abstract][Full Text] [Related]
11. Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study.
Rodríguez LA; Wallander MA; Martín-Merino E; Johansson S
Respir Med; 2010 Nov; 104(11):1691-9. PubMed ID: 20483577
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain).
Román-Rodríguez M; van Boven JF; Vargas F; Contreras CC; Lamelas G; Gestoso S; Góngora M; Corredor M; Esteva M
Eur J Gen Pract; 2016 Dec; 22(4):232-239. PubMed ID: 27597172
[TBL] [Abstract][Full Text] [Related]
13. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
Gershon AS; Campitelli MA; Croxford R; Stanbrook MB; To T; Upshur R; Stephenson AL; Stukel TA
JAMA; 2014 Sep; 312(11):1114-21. PubMed ID: 25226477
[TBL] [Abstract][Full Text] [Related]
14. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
15. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
Ding B; Small M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1753-1763. PubMed ID: 28670116
[TBL] [Abstract][Full Text] [Related]
16. Economic impact of using inhaled corticosteroids without prior exacerbation among elderly patients with chronic obstructive pulmonary disorder.
Chen S; Plauschinat CA; Wu N; Fraser K; Boulanger L
J Med Econ; 2011; 14(4):458-62. PubMed ID: 21651427
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for lung cancer in COPD - results from the Bergen COPD cohort study.
Husebø GR; Nielsen R; Hardie J; Bakke PS; Lerner L; D'Alessandro-Gabazza C; Gyuris J; Gabazza E; Aukrust P; Eagan T
Respir Med; 2019 Jun; 152():81-88. PubMed ID: 31128615
[TBL] [Abstract][Full Text] [Related]
18. Inhaled corticosteroids and the risks of low-energy fractures in patients with chronic airway diseases: A propensity score matched study.
Tsai CH; Liao LY; Lin CL; Chung WS
Clin Respir J; 2018 May; 12(5):1830-1837. PubMed ID: 29148205
[TBL] [Abstract][Full Text] [Related]
19. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
[TBL] [Abstract][Full Text] [Related]
20. Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study.
Janson C; Johansson G; Ställberg B; Lisspers K; Olsson P; Keininger DL; Uhde M; Gutzwiller FS; Jörgensen L; Larsson K
Respir Res; 2018 Sep; 19(1):172. PubMed ID: 30200965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
